The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Dalton James T since 2007.
The trader's CIK number is 1314981.
At the time of the last reporting, Dalton James T was the Vice President of Oncternal Therapeutics, Inc.. (stock ticker symbol ONCT).
Also see all insider trading activities at Oncternal Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2014 | GTXI | 0 | $0 | 72,883 | $94,747 | 0 | $0 |
| 2013 | GTXI | 0 | $0 | 20,000 | $104,019 | 20,000 | $53,000 |
| 2007 | GTXI | 0 | $0 | 17,000 | $0 | 17,000 | $222,190 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-06-06 | GTXI | Sale | 72,883 | 1.30 | 94,747 |
| 2013-01-17 | GTXI | Sale | 20,000 | 5.20 | 104,019 |
| 2013-01-17 | GTXI | Option Ex | 20,000 | 2.65 | 53,000 |
| 2007-03-14 | GTXI | Sale | 17,000 | .00 | 0 |
| 2007-03-14 | GTXI | Option Ex | 17,000 | 13.07 | 222,190 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dalton James T (Vice President of Oncternal Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.